Jump to content


Photo

Counterpoints: Should Treatment for CML Continue Indefinitely?


  • Please log in to reply
1 reply to this topic

#1 gerry

gerry

    Advanced Member

  • Members
  • PipPipPip
  • 1,035 posts

Posted 26 June 2017 - 05:08 PM

Since the advent of tyrosine kinase inhibitors (TKIs), chronic myeloid leukemia (CML) has been transformed from a disease that was usually fatal into one in which patients have a close-to-normal life expectancy. In some cases, the response to treatment is sufficiently prolonged and deep that patients may be able to discontinue their medication. Is this a good idea? In this month's Counterpoints, Drs Nicholas Short and Elias Jabbour argue for the continued treatment of CML, whereas Drs Gabriel Etienne and Fran├žois-Xavier Mahon make the case for treatment discontinuation.

http://www.hematolog...e-indefinitely/

#2 gerry

gerry

    Advanced Member

  • Members
  • PipPipPip
  • 1,035 posts

Posted 26 June 2017 - 05:14 PM

ASCO - US perspective of TKI therapy discontinuation in CML patients


http://www.cmladvoca...in-cml-patients




1 user(s) are reading this topic

0 members, 1 guests, 0 anonymous users